Canquil-400

Canquil-400 Brand names, Canquil-400 Analogs

Canquil-400 Brand Names Mixture

No information avaliable

Canquil-400 Chemical_Formula

C₂₀H₂₃NS

Canquil-400 RX_link

No information avaliable

Canquil-400 fda sheet

Canquil-400 msds (material safety sheet)

Canquil-400 Synthesis Reference

No information avaliable

Canquil-400 Molecular Weight

309.469 g/mol

Canquil-400 Melting Point

< 25 ^oC

Canquil-400 H₂O Solubility

Soluble as HCl salt

Canquil-400 State

Liquid

Canquil-400 LogP

5.7

Canquil-400 Dosage Forms

Tablets (oral, 1 mg)

Canquil-400 Indication

Used for the symptomatic treatment of parkinsonism.

Canquil-400 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Canquil-400 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Canquil-400 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Canquil-400 Patient Information

Canquil-400 Organisms Affected

Humans and other mammals